Search company, investor...
Efficas company logo

Efficas

efficas.com

Founded Year

2003

Stage

Series B | Alive

Total Raised

$24.5M

Last Raised

$16M | 15 yrs ago

About Efficas

Efficas is a biotechnology company focused on the discovery and rapid development of nutritional bioactives with clinically-proven efficacy for the management of human and animal health. Efficas' lead product will be a product derived from an edible fruit to assist in the control of atopic dermatitis.

Headquarters Location

7007 Winchester Circle Suite 120

Boulder, Colorado, 80301,

United States

303-381-2070

Missing: Efficas's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Efficas's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Efficas

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Efficas is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

838 items

Efficas Frequently Asked Questions (FAQ)

  • When was Efficas founded?

    Efficas was founded in 2003.

  • Where is Efficas's headquarters?

    Efficas's headquarters is located at 7007 Winchester Circle, Boulder.

  • What is Efficas's latest funding round?

    Efficas's latest funding round is Series B.

  • How much did Efficas raise?

    Efficas raised a total of $24.5M.

  • Who are the investors of Efficas?

    Investors of Efficas include Burrill & Company, Prolog Ventures, DBL Partners, EQT Life Sciences, Great Spirit Ventures and 6 more.

  • Who are Efficas's competitors?

    Competitors of Efficas include Fujirebio, Molmed, DermTech International, Regado Biosciences, Odyssey Thera and 12 more.

Compare Efficas to Competitors

I
InsectiGen

InsectiGen, Inc. is a biotechnology company focused on discovery and development of biopesticides. Founded by Clifton Baile, PhD and Michael Adang PhD, InsectiGen has licensed IP from the University of Georgia associated with modified proteins form the intestine of insects that enhance natural insecticides produced by Bacillus thuringensis (Bt).

A
Arisyn Therapeutics

Arisyn Therapeutics Inc. is a biotechnology company focused on the development of first in class inhibitors of infectious disease and cancer. Arisyn possesses a portfolio of small molecule compounds that will be developed to treat Human Immunodeficiency Virus-Type 1 (HIV-1), Human Immunodeficiency Virus-Type 2 (HIV-2), Human T-Lymphotropic Virus-Type 1 (HTLV-1), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Herpes Simplex Virus-Type 2 (HSV-2). Arisyn will perform all necessary studies required to develop these therapeutic agents through Phase 1 and Phase 2 human clinical trials.

P
ParaTechs

ParaTechs applies advances in insect molecular biology to identify genes and proteins from insect parasites and pathogens that can be used for insect control and natural product development. ParaTech also markets products that enable discovery and development in biotechnology.

O
Origin BioMed

Origin BioMed Inc., is an innovative biotechnology company currently expanding the markets for its exclusive pain relief,diabetic, skin and lip care products.

V
Vybion

Vybion is a developer and manufacturer of recombinant proteins for therapeutic and diagnostic applications. It uses its technologies along with a highly skilled staff to develop therapeutics, vaccines, diagnostics and bioavailability for pharmaceutical and biotechnology companies.

A
ADV Bioscience

ADV Bioscience is a biotechnology service company engaged in the application of self-developed, public domain technologies and licensed technologies primarily for gene discovery research and validation. The company's focus is offering these technologies primarily to the Chinese market.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.